Drugs fix

CMS CameronMcKenna Nabarro Olswang’s Borys Danevychand Artem Grudinin provide solutions tocombat the rising threat of drug counterfeits

Borys Danevychand Artem Grudinin, CMS CameronMcKenna Nabarro Olswang

Drug counterfeiting, one of the most lucrative tradeopportunities in fake goods, constitutes a global issue for pharmaceuticalcompanies. The circulation of counterfeit drugs causes significant financialand reputational losses for drug manufacturers. On the one hand, the companysuffers financial losses while the patient pays for counterfeits instead ofgenuine therapy. On the other hand, both the patient and the attendingphysician, unaware that the patient is receiving a fake, may come to wrongconclusions about the drug efficacy and adverse effects.